OMICOP – D

OMICOP – D is a comprehensive gastroprotective formulation designed to effectively manage acid reflux, heartburn, gastroesophageal reflux disease (GERD), and other digestive discomforts. It combines the powerful acid-suppressing action of Omeprazole with Domperidone, a prokinetic agent, providing dual-action relief that targets both excessive stomach acid and delayed gastric emptying.

The Omeprazole component works by inhibiting proton pumps in the stomach lining, significantly reducing the production of stomach acid. This helps alleviate symptoms like acidity, heartburn, and burning sensation in the chest. Meanwhile, Domperidone improves gastrointestinal motility, facilitating faster stomach emptying, reducing nausea, bloating, and preventing vomiting, which are common problems associated with acid-related digestive disorders.

OMICOP – D is particularly suitable for patients suffering from GERD, peptic ulcers, functional dyspepsia, and chronic acid indigestion. Its dual-action formula ensures rapid symptomatic relief while also addressing the underlying causes of gastric discomfort, making it an effective solution for both immediate and long-term digestive health.

This medicine is well-tolerated and safe for adult use when taken under medical supervision. Regular use helps patients regain comfort, restore normal digestive function, and prevent recurrence of acid-related symptoms. By combining acid suppression and enhanced gastric motility, OMICOP – D provides a balanced approach to managing complex gastrointestinal conditions.

Trusted for its efficacy and reliability, OMICOP – D ensures patients experience lasting relief from heartburn, acidity, and gastric discomfort, while promoting overall digestive wellness and improved quality of life. Its dual-action benefits make it a preferred choice among healthcare professionals for effective management of acid-related disorders.